What is the aim of the LEADe study?
The LEADe study was a randomized controlled trial of atorvastatin in mild to moderate Alzheimer disease. The aim of the study was to assess the efficacy and safety of the drug in this population, as well as to determine whether its use could potentially reduce the risk of cognitive decline and the progression of the disease.